United States · FDA National Drug Code directory
neostigmine methylsulfate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-995_8265ddeb-9723-49af-85fa-0699c4c3c6d7
- Product NDC
- 31722-995
- Form
- INJECTION
- Composition / generic term
- neostigmine methylsulfate
- Labeler
- Camber Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210104
- Source listing expiry
- 20261231
Source-listed ingredients
- NEOSTIGMINE METHYLSULFATE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, MULTI-DOSE in 1 CARTON (31722-995-31) / 10 mL in 1 VIAL, MULTI-DOSE · 31722-995-31
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →